$12.92
-2.5%SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $100 million. The fund invests in companies with revenues between $50 million and $1 billion and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.
Chairman, President & Co-Chief Executive Officer
Chief Financial Officer & Treasurer
Co-Chief Executive Officer, Chief Operating Officer & Interested Director
Corporate Secretary & Chief Compliance Officer
Head of Healthcare Venture Lending
Investor Relations
During the last 12 months, insiders have purchased $3.97M worth of SLRC shares, with no selling activity reported.
55.5K
754.95K
0
0.00
+755K
+$755K
209.6K
3.09M
0
0.00
+3.1M
+$3.09M
7.2K
120.25K
0
0.00
+120K
+$120K
0
0.00
0
0.00
+0
+$0
Gross Michael S
Director, Officer: See Remarks
$2.30M
Spohler Bruce J
Director, Officer: See Remarks
$1.55M
Roberts Andrea Colvin
Director
$120K
No selling activity
Strong bullish signal with $3.97M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
3 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
SLRC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | October 08, 2025 | November 19, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | October 09, 2024 | November 20, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | October 04, 2023 | November 15, 2023 | 2023 | |
DEF 14A DEF 14A N/A | September 12, 2022 | September 12, 2022 | ||
DEF 14A DEF 14A 2021 N/A | September 09, 2021 | October 27, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | August 21, 2020 | October 06, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | August 15, 2019 | October 08, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | August 17, 2018 | October 11, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 29, 2017 | May 17, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | April 25, 2016 | June 07, 2016 | 2016 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.